25 / 74 · 1:10 · Original AXON film
Cerebrolysin
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
A mixture, not one molecule
Cerebrolysin is a mixture of small peptides and amino acids derived from porcine brain tissue. It is not one precisely defined signaling peptide. [1] [2]
Mechanistic work: rat cell cultures
Researchers have investigated effects on cell survival and signaling. For example, an early experiment used rat microglial and astrocyte cultures, not patients recovering brain function. [1]
Clinical outcomes and harms both matter
Human outcomes need separate evidence. A 2023 Cochrane review found no convincing mortality benefit in acute ischemic stroke and raised concern about nonfatal serious adverse events. [2]
Mechanism does not establish a treatment claim
The manufacturer states Cerebrolysin is not approved in the United States. A neurotrophic research rationale should not be presented as proof of brain regeneration or a general cognitive boost. [3]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Effects of Cerebrolysin on primary microglial and astrocyte rat cell cultures (1999) →Porcine-derived preparation and rat-cell experimental context.
- Cochrane (2023): Cerebrolysin for acute ischaemic stroke →Mortality and serious-adverse-event findings in acute stroke.
- Cerebrolysin manufacturer: US regulatory notice →Manufacturer states no US approval for sale/distribution.
